GSM城市站国家站国际

澳大利亚政府11月15日宣布扩大 Zolgensma 补贴范围:脊髓性肌萎缩症适用儿童放宽至21公斤,无补贴费用逾250万澳元

2026-11-15 · 世界 · GSM News
澳大利亚政府11月15日宣布扩大 Zolgensma 补贴范围:脊髓性肌萎缩症适用儿童放宽至21公斤,无补贴费用逾250万澳元

澳大利亚政府11月15日宣布,通过药品福利计划(PBS)扩大基因疗法 Zolgensma 的列入补贴名单,让更多幼儿获得这一治疗脊髓性肌萎缩症的药物。

自2026年11月1日起,Zolgensma 的适用范围从9个月以下婴儿扩大到体重不超过21公斤的符合条件儿童。脊髓性肌萎缩症是一种罕见的遗传病,影响控制肌肉运动的神经,导致进行性肌肉无力和萎缩,最严重时可致瘫痪和死亡。政府表示,每35名澳大利亚人中就有1人在不知情的情况下携带该病基因,每10000名在澳大利亚出生的婴儿中有1人患病。

Zolgensma 是一次性基因疗法,通过递送 SMN1 基因的功能拷贝,处理该病的根本遗传原因。没有 PBS 补贴时,这项一次性治疗费用可超过250万澳元。政府预计每年最多有5名儿童从这一列入补贴名单 受益。自2022年7月以来,政府已资助超过500项新的和修订的 PBS列入补贴名单。

卫生部长 Mark Butler 表示,Zolgensma 是一次性、变革性的治疗,治疗时机对脊髓性肌萎缩症至关重要,但超过250万澳元的费用让家庭难以承受,政府正让更多家庭能够负担这一治疗。

Australia Expands PBS Listing of Zolgensma on 15 November: Eligible Children With Spinal Muscular Atrophy Up to 21 Kilograms, Treatment Costs Over 2.5 Million Dollars Without Subsidy

The Australian Government announced on 15 November that it is giving more young children access to a life-changing gene therapy for spinal muscular atrophy, through an expanded listing of Zolgensma on the Pharmaceutical Benefits Scheme (PBS).

From 1 November 2026, access to Zolgensma (onasemnogene abeparvovec) has been expanded from babies up to 9 months to eligible children up to 21 kilograms in weight. Spinal muscular atrophy is a rare inherited genetic condition that affects the motor neurons controlling muscle movement, causing progressive muscle weakness and wasting, and in its most severe forms paralysis and death. One in 35 Australians unknowingly carry the gene and one in 10,000 babies born in the country is affected.

Zolgensma is a one-time gene therapy designed to address the underlying genetic cause by delivering a functional copy of the SMN1 gene. Without PBS subsidy, the treatment could cost patients more than 2.5 million dollars. It is expected up to five children will benefit from the listing each year, and the government said it has now funded over 500 new and amended PBS listings since July 2022.

Minister for Health Mark Butler said Zolgensma is a one-off, transformative treatment, timing is critical, and at a cost of over 2.5 million dollars it is out of reach for families, adding that the government is making the treatment available and affordable for more families.

发布:GSM·美国(发布链接)

图片来源:Wikimedia Commons, File:Parliament House at dusk, Canberra ACT.jpg — Author: Thennicke. Licensing: Creative Commons Attribution-Share Alike 4.0 (CC BY-SA 4.0).

GSM Global · 本篇英文版 English edition of this story

本频道最新更多 ›

← 返回世界 全部新闻 关于我们

GSM首页白宫联邦加州南加各州社会军事司法选举世界中国城市站国家站移民宣传专题视频直播放映厅电子书电子报科技金融教育医疗影视音乐体育文旅时尚演出活动娱乐游戏生活美食户外交通汽车地产保险儿童长者留学生宠物信仰非盈利机构